Analysis of progression free survival versus overall survival in melanoma
Analysis of progression free survival versus overall survival in melanoma
Androgen blockade and ipilimumab against castration resistant prostate cancer
Editor’s Choice - ecancermedicalscience September 2013
Targeting and inhibiting IKK-alpha in prostate cancer
Role of metronomics in cancer clinical trials and practice in developing countries
Improving predictability of clinical trial outcomes
Development of clinical decision support tools for physicians and patients
Identifying and applying molecular subgrouping in colorectal cancer
Treatment of melanoma in Latin America
Highlights from EHA 2013
Challenges facing haematologists treating acute myeloid leukaemia
JAK-STAT pathway in malignant and non-malignant cells in myeloproliferative neoplasms